Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04021537 · ClinicalTrials.gov registry record · NA
Non-invasive Nerve Stimulation and Sleep
A NA study of PTSD, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 87
- Enrollment target
- 1
- Study location
NCT04021537: Active NA study of PTSD, sponsored by VA Office of Research and Development.
NCT04021537 is a NA study of PTSD that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 87 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04021537, a NA study of PTSD, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
People often have difficulty sleeping. Reasons are many. But, difficulty falling and staying asleep are common issues. Sleep difficulties are common in disorders such as Post Traumatic Stress Disorder. Current treatments for sleep difficulties are not effective for everyone. Better treatments are needed. In this study, the investigators are testing two nerve stimulation locations that may impact brain function in such a way that sleep is improved.
Primary Outcome
Polysomnography measures. Slow wave sleep time. Rem sleep time.
Conditions Studied
Interventions
- DEVICE non-invasive nerve stimulation
Study Locations (1)
Florida
- North Florida/South Georgia Veterans Health System, Gainesville, FL - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What the registry record for NCT04021537 still lists
NCT04021537 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (71% lower).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which non-invasive nerve stimulation is the first listed.
NCT04021537 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04021537 about?
NCT04021537 is a clinical study titled "Non-invasive Nerve Stimulation and Sleep". People often have difficulty sleeping. Reasons are many. But, difficulty falling and staying asleep are common issues. Sleep difficulties are common in disorders such as Post Traumatic Stress Disorder. Current treatments for sleep difficulties are not effective for everyone. Better treatments are ne...
What is the current status of trial NCT04021537?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 87 participants. The study started on 2020-01-30. Estimated completion is 2026-10-01.
What conditions does trial NCT04021537 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT04021537?
The interventions under investigation include: non-invasive nerve stimulation (DEVICE).
Who is sponsoring clinical trial NCT04021537?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04021537 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04021537's enrollment target sits among peer trials
87 71st of 154 higher than 84 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI